Abstract
We have investigated the effectiveness of chemotherapy for patients with recurrent adeno- and adenoidcystic carcinomas in the head and neck. Fourteen cases received a monthly combination chemotherapy regimen of cyclophosphamide, pirarubicin and cisplatin (CAP therapy). A response rate of 36% (5/14) was achieved. There was one complete response and four partial responses. The median duration of response was 37 months in the complete response case and 16 months (range, 6 to 20) in the partial response cases. The toxicity of this chemotherapy was acceptable. The result demonstrates that CAP therapy is an effective regimen for adeno- and adenoidcystic carcinomas. It may also be available as induction or adjuvant chemotherapy for patients with advanced tumors of these cancers.
Key words: Adeno- and adenoidcystic carcinomas, Head and neck, CAP therapy, Response
References
- Belani CP, Eisenberger MA, Gray C (1988) Preliminary experience with chemotherapy in advanced salivary gland neoplasms. Med Pediatr Oncol 16:197–202 [DOI] [PubMed] [Google Scholar]
- Creagan ET, Woods JE, Schutt AJ, Ofallon JR (1983) Cyclophosphamide, Adriamycin, andcis-diamminedichloro-platinum II in the treatment of advanced nonsquamous cell head and neck cancer. Cancer 52:2007–2010 [DOI] [PubMed] [Google Scholar]
- Creagan ET, Woods JE, Rubin J, Schaid DJ (1988) Cisplatin based chemotherapy for neo-plasms arising from salivary glands and contiguous structures in the head and neck. Cancer 62:2313–2319 [DOI] [PubMed] [Google Scholar]
- Devita VT, Hellman S, Rosenberg SA (1985) Cancer, principles and practive of oncology, 2nd edn. Lippincott, Philadelphia [Google Scholar]
- Dreyfuss AI, Clark JR, Fallon BG, Posner MR, Norris CM, Miller D (1987) Cyclophosphmaide, doxorubicin and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer 60:2869–2872 [DOI] [PubMed] [Google Scholar]
- Eisenberger MA (1985) Supporting evidence for an active treatment program for advanced salivary gland carcinomas. Cancer Treat Rep 69:319–321 [PubMed] [Google Scholar]
- Fu KK, Liebel SA, Levine ML (1977) Carcinoma of the major and minor salivary glands. Cancer 40:2882–2890 [PubMed] [Google Scholar]
- Haan LD de, Mulder HM de, Vermorken JB, Schornagel JH, Vermey A, Verweij J (1992) Cisplating-based chemotherapy in advanced adenoidcystic carcinoma of the head and neck. Head Neck 14:273–277 [DOI] [PubMed] [Google Scholar]
- Hesketh PJ, Gandara DR (1991) Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst 83:613–620 [DOI] [PubMed] [Google Scholar]
- Kaplan MJ, Johns ME, Cantrell RW (1986) Chemotherapy for salivary gland cancer. Otolaryngol Head Neck Surg 95:165–170 [DOI] [PubMed] [Google Scholar]
- Posner MR, Erbin TJ, Weichselbaum RR, Fabian RL, Miller D (1982) Chemotherapy of advanced salivary gland neoplasms. Cancer 50:2261–2264 [DOI] [PubMed] [Google Scholar]
- Venook AP, Tseng A, Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD (1987) Cisplatin, doxorubicin and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the northern California oncology group. J Clin Oncol 5:951–955 [DOI] [PubMed] [Google Scholar]